4.7 Article

circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer

Zelin Hou et al.

Summary: VISTA expression in tumor cells is associated with favorable prognosis in pancreatic cancer patients. The study showed that VISTA level is positively correlated with different immune cell subclusters in PDAC, and anti-VISTA therapy can effectively reduce metastatic nodules in mouse models with liver metastases of PDAC.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Cellular based immunotherapy for primary liver cancer

Yuanyuan Zheng et al.

Summary: Cellular based immunotherapy, with its natural advantages in PLC treatment by involving both lymphoid and myeloid cells, is promising. However, there are still obstacles and challenges in PLC treatment that need to be addressed through comprehensive immunotherapeutic approaches.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Pharmacology & Pharmacy

Targeting CD73 to augment cancer immunotherapy

Meejeon Roh et al.

CURRENT OPINION IN PHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

Galectin-8 in the onset of the immune response and inflammation

Maria Tribulatti et al.

GLYCOBIOLOGY (2020)

Article Biochemistry & Molecular Biology

The Landscape of Circular RNA in Cancer

Josh N. Vo et al.

Article Biochemistry & Molecular Biology

Genome-wide identification of cancer-specific alternative splicing in circRNA

Jing Feng et al.

MOLECULAR CANCER (2019)

Article Biochemistry & Molecular Biology

Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression

Peng-Fei Zhang et al.

MOLECULAR CANCER (2019)

Editorial Material Immunology

Potential of CD73 as a target for cancer immunotherapy

Farhad Jadidi-Niaragh

IMMUNOTHERAPY (2019)

Review Pharmacology & Pharmacy

CD73 as a potential opportunity for cancer immunotherapy

Ghasem Ghalamfarsa et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2019)

Article Gastroenterology & Hepatology

Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma

Jian Yu et al.

JOURNAL OF HEPATOLOGY (2018)

Review Biochemistry & Molecular Biology

The Biogenesis, Functions, and Challenges of Circular RNAs

Xiang Li et al.

MOLECULAR CELL (2018)

Article Biotechnology & Applied Microbiology

Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance

Rui Peng et al.

ONCOTARGETS AND THERAPY (2017)

Article Oncology

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Suzanne L. Topalian et al.

CANCER CELL (2015)

Article Gastroenterology & Hepatology

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

John Bridgewater et al.

JOURNAL OF HEPATOLOGY (2014)

Article Multidisciplinary Sciences

Natural RNA circles function as efficient microRNA sponges

Thomas B. Hansen et al.

NATURE (2013)

Review Biochemistry & Molecular Biology

Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies

D. Sia et al.

ONCOGENE (2013)

Article Oncology

Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor-Positive, Lower Grade Breast Cancer

Roger L. Milne et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)

Letter Biochemistry & Molecular Biology

ceRNAs: miRNA Target Mimic Mimics

Ignacio Rubio-Somoza et al.

Review Oncology

CD73: A Novel Target for Cancer Immunotherapy

Bin Zhang

CANCER RESEARCH (2010)

Review Oncology

Galectins - Potential targets for cancer therapy

Syed Saif Hasan et al.

CANCER LETTERS (2007)